RAAY vs. ARKG

Last updated Jul 10, 2026

RAAY (Reckoner Yield Enhanced AAA CLO Annual ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - RAAY is a Actively Managed fund actively managed by Reckoner, while ARKG is a Health & Biotech Equities fund actively managed by ARK. Both are actively managed. At a correlation of -0.03, they often move in opposite directions. RAAY charges 0.35%/yr vs 0.75%/yr for ARKG.

Performance

RAAY vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Reckoner Yield Enhanced AAA CLO Annual ETF (RAAY) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

RAAY

• 1D: 0.00%
• 1M: 0.49%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ARKG

• 1D: 2.70%
• 1M: 28.13%
• 6M: 39.11%
• YTD: 48.43%
• 1Y: 64.94%
• 3Y*: 7.24%
• 5Y*: -13.62%
• 10Y*: 9.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RAAY vs. ARKG - Yearly Performance Comparison

	2026 (YTD)
RAAY Reckoner Yield Enhanced AAA CLO Annual ETF	1.99%
ARKG ARK Genomic Revolution Multi-Sector ETF	47.61%

Correlation

The correlation between RAAY and ARKG is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (All Time) Calculated using the full available price history since Feb 11, 2026	-0.03

Return for Risk

RAAY vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RAAY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

ARKG

ARKG Risk / Return Rank: 53
ARKG Sharpe Ratio Rank: 56
ARKG Sortino Ratio Rank: 59
ARKG Omega Ratio Rank: 49
ARKG Calmar Ratio Rank: 60
ARKG Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RAAY vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Reckoner Yield Enhanced AAA CLO Annual ETF (RAAY) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RAAY	ARKG	Difference
Sharpe ratio: Return per unit of total volatility	—	1.52	—
Sortino ratio: Return per unit of downside risk	—	2.22	—
Omega ratio: Gain probability vs. loss probability	—	1.25	—
Calmar ratio: Return relative to maximum drawdown	—	2.37	—
Martin ratio: Return relative to average drawdown	—	5.65	—

Drawdowns

RAAY vs. ARKG - Drawdown Comparison

The maximum RAAY drawdown since its inception was -0.62%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for RAAY and ARKG.

Drawdown Indicators

	RAAY	ARKG	Difference
Max Drawdown Largest peak-to-trough decline	-0.62%	-83.59%	+82.97%
Max Drawdown (1Y) Largest decline over 1 year	—	-27.51%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-51.96%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-79.49%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-83.59%	—
Current Drawdown Current decline from peak	0.00%	-61.53%	+61.53%
Average Drawdown Average peak-to-trough decline	-0.08%	-36.11%	+36.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	11.53%	—

Volatility

Volatility by Period

	RAAY	ARKG	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	11.67%	—
Volatility (6M) Calculated over the trailing 6-month period	—	31.52%	—
Volatility (1Y) Calculated over the trailing 1-year period	1.37%	43.05%	-41.68%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	1.37%	46.11%	-44.74%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	1.37%	41.36%	-39.99%

RAAY vs. ARKG - Expense Ratio Comparison

RAAY has a 0.35% expense ratio, which is lower than ARKG's 0.75% expense ratio.

Dividends

RAAY vs. ARKG - Dividend Comparison

Neither RAAY nor ARKG has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%
RAAY Reckoner Yield Enhanced AAA CLO Annual ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both RAAY and ARKG in my portfolio?

RAAY and ARKG have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, RAAY or ARKG?

On fees, RAAY is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, RAAY or ARKG?

RAAY is cheaper with a 0.35% expense ratio, compared with 0.75% for ARKG.

Which ETF pays a higher dividend yield, RAAY or ARKG?

RAAY and ARKG have nearly identical dividend yields, around 0.00%.

What is the main difference between RAAY and ARKG?

RAAY is categorized as Actively Managed, while ARKG is Health & Biotech Equities. They also come from different issuers: Reckoner and ARK. Their fees differ too: 0.35% for RAAY and 0.75% for ARKG.